ArticleCancer management and research2025
Impact of Intravenous Fish Oil Lipid Emulsion on Short-Term Postoperative Outcomes in Rectal Cancer Patients Following Neoadjuvant Therapy: A Propensity Score-Matched Study.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Previous studies lack a consensus on the role of fish oil lipid emulsion in postoperative complications and recovery in rectal cancer patients post-neoadjuvant therapy. This study aimed to evaluate the impact of intravenous fish oil lipid emulsion on short-term clinical outcomes in these patients. Patients and Methods: This retrospective study included patients who underwent radical surgery for RC after NT between November 2018 and April 2022. Patients were divided into two groups: the fish oil group (receiving fish oil treatment) and the control group (not receiving fish oil treatment). Propensity Score Matching was used to analyze and compare postoperative complications and other relevant clinical indicators between the two groups. A total of 208 patients were included, with 33 patients in each group after PSM. Results: The results showed no significant differences between the two groups in terms of time to first flatus, time to first defecation, or time to first liquid diet intake (p > 0.05). However, compared to the control group, the fish oil group had significantly lower rates of postoperative complications, shorter hospital stays, and earlier tolerance to solid food (p < 0.05). Additionally, the fish oil group effectively suppressed the decline in postoperative albumin levels (p < 0.05). Conclusion: These findings suggest that perioperative intravenous supplementation of fish oil may effectively reduce postoperative complications, accelerate recovery, and improve postoperative nutritional status in rectal cancer patients post-neoadjuvant therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.